100 related articles for article (PubMed ID: 1504995)
1. [Favorable effect of methylprednisolone pulse therapy in dysphagia and primary idiopathic polymyositis/dermatomyositis].
Hrncír Z
Cas Lek Cesk; 1992 Jul; 131(13):399-401. PubMed ID: 1504995
[TBL] [Abstract][Full Text] [Related]
2. [Use of intravenous megadoses of methylprednisolone for treatment of dermatomyositis in children].
Romicka AM
Pediatr Pol; 1995 Mar; 70(3):243-8. PubMed ID: 8657493
[TBL] [Abstract][Full Text] [Related]
3. [Long-term study of diffuse connective tissue disease after methylprednisolone pulsed therapy].
Hrncír Z; Bradna P; Nozicková H; Tichý M
Vnitr Lek; 1991 Jan; 37(1):63-72. PubMed ID: 2058099
[TBL] [Abstract][Full Text] [Related]
4. [Methylprednisolone pulse therapy in active polymyositis/dermatomyositis].
Hrncír Z; Bradna P; Pidrman V; Tichý M
Vnitr Lek; 1988 Apr; 34(4):376-83. PubMed ID: 3394263
[No Abstract] [Full Text] [Related]
5. Dysphagia in dermatomyositis secondary to bladder cancer: rapid response to combined immunoglobulin and methylprednisolone.
Hafejee A; Coulson IH
Clin Exp Dermatol; 2005 Jan; 30(1):93-4. PubMed ID: 15663519
[No Abstract] [Full Text] [Related]
6. [Clinical analysis of 11 cases of juvenile dermatomyositis and polymyositis].
Ito S; Miyamae T; Imagawa T; Katakura S; Mori M; Tomono J; Ibe M; Mituda T; Aihara Y; Yokota S
Ryumachi; 1998 Dec; 38(6):785-92. PubMed ID: 10047716
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and limitations of pulse cyclophosphamide therapy in polymyositis and dermatomyositis.
Nagappa M; Taly AB; Sinha S; Gayathri N; Bindu PS; Mahadevan A; Yasha T
J Clin Neuromuscul Dis; 2013 Jun; 14(4):161-8. PubMed ID: 23703010
[TBL] [Abstract][Full Text] [Related]
8. [Pulse therapy in severe dermato/polymyositis with respiratory paralysis].
Magalhães IL; Flaquer LF; Balthazar PA; Pastor EH; Giovani L; Yoshinari NH
Rev Hosp Clin Fac Med Sao Paulo; 1986; 41(3):136-40. PubMed ID: 3563303
[No Abstract] [Full Text] [Related]
9. Influence of age at onset on the duration of treatment in idiopathic adult polymyositis and dermatomyositis.
McKendry RJ
Arch Intern Med; 1987 Nov; 147(11):1989-91. PubMed ID: 3675101
[TBL] [Abstract][Full Text] [Related]
10. Oropharyngeal dysphagia in polymyositis/dermatomyositis.
Ertekin C; Seçil Y; Yüceyar N; Aydoğdu I
Clin Neurol Neurosurg; 2004 Dec; 107(1):32-7. PubMed ID: 15567550
[TBL] [Abstract][Full Text] [Related]
11. [Clinical characteristics of juvenile dermatomyositis].
Constantin T; Ponyi A; Garami M; Gergely L; Fekete G; Dankó K
Orv Hetil; 2003 Jun; 144(25):1245-50. PubMed ID: 12901181
[TBL] [Abstract][Full Text] [Related]
12. Intravenous immunoglobulins as treatment of life threatening esophageal involvement in polymyositis and dermatomyositis.
Marie I; Hachulla E; Levesque H; Reumont G; Ducrotte P; Cailleux N; Hatron PY; Devulder B; Courtois H
J Rheumatol; 1999 Dec; 26(12):2706-9. PubMed ID: 10606390
[TBL] [Abstract][Full Text] [Related]
13. [Dermatomyositis and polymyositis: clinical aspects and treatment].
Hachulla E
Ann Med Interne (Paris); 2001 Nov; 152(7):455-64. PubMed ID: 11965087
[TBL] [Abstract][Full Text] [Related]
14. Medium- and long-term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis.
Huber AM; Lang B; LeBlanc CM; Birdi N; Bolaria RK; Malleson P; MacNeil I; Momy JA; Avery G; Feldman BM
Arthritis Rheum; 2000 Mar; 43(3):541-9. PubMed ID: 10728746
[TBL] [Abstract][Full Text] [Related]
15. A pilot study: use of fludarabine for refractory dermatomyositis and polymyositis, and examination of endpoint measures.
Adams EM; Pucino F; Yarboro C; Hicks JE; Thornton B; McGarvey C; Sonies BC; Bartlett ML; Villalba ML; Fleisher T; Plotz PH
J Rheumatol; 1999 Feb; 26(2):352-60. PubMed ID: 9972969
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of Grave's ophthalmopathy with high doses of corticosteroids].
Cirić J; Zarković M; Stojanović M; Pepenezić Z; Randjelović G; Gligorović M; Trbojević B; Drezgić M; Nesović M
Srp Arh Celok Lek; 2000; 128(5-6):179-83. PubMed ID: 11089418
[TBL] [Abstract][Full Text] [Related]
17. [Methylprednisolone pulse therapy for SLE patients with CNS disorder].
Ichikawa Y; Hashimoto H; Kashiwazaki S; Kondo H; Akizuki M; Tokanou Y
Ryumachi; 1994 Aug; 34(4):733-43. PubMed ID: 7974024
[TBL] [Abstract][Full Text] [Related]
18. [Polymyositis and dermatomyositis in childhood].
Rodríguez Núñez A; Fernández Bustillo JM; Rodríguez Pérez E; Novo Rodríguez I; Pérez Becerra E; Peña Guitián J; Castro Gago M
An Esp Pediatr; 1988 Oct; 29(4):288-92. PubMed ID: 3069018
[TBL] [Abstract][Full Text] [Related]
19. [Two cases of amyopathic dermatomyositis with fatal rapidly progressive interstitial pneumonitis].
Tokiyama K; Tagawa H; Yokota E; Nagasawa K; Kusaba T; Tsuda Y; Niho Y
Ryumachi; 1990 Jun; 30(3):204-9; discussion 209-11. PubMed ID: 2244255
[TBL] [Abstract][Full Text] [Related]
20. Polymyositis-dermatomyositis:25 years of follow-up of 50 patients disease course, treatment, prognostic factors.
Chwalińska-Sadowska H; Małdykowa H
Mater Med Pol; 1990; 22(3):213-8. PubMed ID: 2132429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]